Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sight Sciences (SGHT) EBT (2020 - 2025)

Sight Sciences (SGHT) has 6 years of EBT data on record, last reported at -$4.2 million in Q4 2025.

  • For Q4 2025, EBT rose 64.82% year-over-year to -$4.2 million; the TTM value through Dec 2025 reached -$38.4 million, up 25.07%, while the annual FY2025 figure was -$38.4 million, 25.07% up from the prior year.
  • EBT reached -$4.2 million in Q4 2025 per SGHT's latest filing, up from -$8.2 million in the prior quarter.
  • Across five years, EBT topped out at -$4.2 million in Q4 2025 and bottomed at -$23.8 million in Q2 2022.
  • Average EBT over 5 years is -$14.7 million, with a median of -$14.4 million recorded in 2023.
  • Peak YoY movement for EBT: crashed 128.78% in 2021, then surged 64.82% in 2025.
  • A 5-year view of EBT shows it stood at -$15.8 million in 2021, then dropped by 6.69% to -$16.9 million in 2022, then surged by 36.79% to -$10.7 million in 2023, then decreased by 10.55% to -$11.8 million in 2024, then surged by 64.82% to -$4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$4.2 million in Q4 2025, -$8.2 million in Q3 2025, and -$11.9 million in Q2 2025.